Literature DB >> 15950801

Malignant pleural mesothelioma: staging systems.

P Van Schil1.   

Abstract

Malignant pleural mesothelioma has a very specific growth pattern invading the pleural surfaces and neighboring structures. For this reason precise estimation of tumor volume and description of local extension are particularly difficult. Different staging systems have been introduced, and the most widely used are discussed. Restaging of mesothelioma after induction therapy is even more complicated and still controversial. The recently described, modified response evaluation criteria in solid tumors (RECIST) criteria are presently the most accurate for response evaluation.

Entities:  

Mesh:

Year:  2005        PMID: 15950801     DOI: 10.1016/j.lungcan.2005.03.008

Source DB:  PubMed          Journal:  Lung Cancer        ISSN: 0169-5002            Impact factor:   5.705


  3 in total

1.  Treatment of mesothelioma: still a long way to go!

Authors:  Paul E Van Schil
Journal:  Chin J Cancer Res       Date:  2013-04       Impact factor: 5.087

Review 2.  Making the case for molecular staging of malignant pleural mesothelioma.

Authors:  Raphael Bueno
Journal:  Semin Thorac Cardiovasc Surg       Date:  2009

3.  Mesothelioma in the United States: a Surveillance, Epidemiology, and End Results (SEER)-Medicare investigation of treatment patterns and overall survival.

Authors:  Jennifer L Beebe-Dimmer; Jon P Fryzek; Cecilia L Yee; Tapashi B Dalvi; David H Garabrant; Ann G Schwartz; Shirish Gadgeel
Journal:  Clin Epidemiol       Date:  2016-10-26       Impact factor: 4.790

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.